Phase I Study of Pazopanib in Combination With Lapatinib or Trastuzumab in Subjects With Solid Tumors.
Phase of Trial: Phase I
Latest Information Update: 07 Jun 2016
At a glance
- Drugs Lapatinib (Primary) ; Pazopanib (Primary) ; Trastuzumab (Primary)
- Indications Solid tumours
- Focus Adverse reactions; Therapeutic Use
- 07 Jun 2016 Results of a retrospective analysis of pazopanib from 4 phase I trials in patients with advanced sarcoma (NCT01339871, NCT01430572, NCT01454804, NCT01454804) presented at the 52nd Annual Meeting of the American Society of Clinical Oncology.
- 16 Mar 2015 Status changed from active, no longer recruiting to discontinued, as reported by M.D. Anderson Cancer Center.
- 13 Mar 2015 Status changed from active no longer recruiting to completed as reported by ClinicalTrials.gov record.